ARCHIVES

NCI Exceeded Mandate In Study Of Legislators, Rep. Porter Says

This article is from The Cancer Letter archive.

Vol. 21 No. 32 | August 11, 1995

Download PDF Visit The Full Archive

Related Articles

Senate “Pleased” About Reductions In Incidence And Mortality

October 8, 1999

New Treatment For CML Could Be Model for Molecular Target-Based Therapeutics

December 10, 1999

Sixty CCOPs Could cost $16 Million; DCPC Staff Believes They Can Get It

October 10, 1986

New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet,

January 19, 2007

Genetronics Phase II Trials For Head & Neck Completed.

May 4, 2001

Bennett, CCIRC Members Disagree On state Of Groups, Simons New Chairman

June 27, 1980